Steven Cohen’s Harmony Biosciences HRMY Stock Holding History

Steven Cohen’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,100	Closed	-$278K	–	4008
2025 Q3	$278K	Buy	+10,100	New	+$348K	﹤0.01%	2086

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Steven Cohen's HRMY Position: Q3 2025 in Review

Steven Cohen sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 33,778 shares — an estimated $1.16M sold.

Steven Cohen first reported a position in HRMY in Q2 2021 and held it in 3 quarters. The position peaked at $3.22M in Q2 2021. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

Steven Cohen reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
Steven Cohen sold 33,778 Harmony Biosciences shares in Q3 2025, an estimated $1.16M.
Steven Cohen first reported a position in Harmony Biosciences in Q2 2021 and held it in 3 quarters.
Steven Cohen's Harmony Biosciences position peaked at $3.22M in Q2 2021.
296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.